Relationship of the K-ras/c-mos expression patterns with angiogenesis in non-small cell lung carcinomas

Molecular Medicine

Volumn 7, Issue 9, 2001, Pages 590-597

  Zacharatos, Panayotis ^a   Kotsinas, Athanassios ^a   Tsantoulis, Petros ^a   Evangelou, Kostas ^a   Kletsas, Dimitris ^a   Asimacopoulos, Panayiotis J ^a   Doussis Anagnostopoulou, Ipatia ^a   Pezzella, Francesco ^a   Gatter, Kevin ^a   Papavassiliou, Athanasios G ^a   Kittas, Christos ^a   Gorgoulis, Vassilis G ^a  

^a NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; ONCOPROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MICROVASCULATURE; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; TUMOR GROWTH;

EID: 0035716137     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401865     Document Type: Article

References (41)

1. What is the evidence that tumors are angiogenesis dependent
2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
3. Molecular mechanisms of blood vessel formation
4. Vascular-specific growth factors and blood vessel formation
5. Vascular permeability factor/vascular endothelial growth factor, microvascular hypermeability and angiogenesis
6. Hypoxia induction of human vascular endothelial growth factor expression through c-Src activation
7. Both v-Ha-ras and v-raf stimulate expression of the vascular endothelial growth factor in NIH3T3 cells
8. Oncogenes and tumor angiogenesis: Differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts
9. Ras proteins in the control of the cell cycle and cell differentiation
10. Complexes of Ras. GTP with Raf and mitogen-activated protein kinase kinase
11. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers
12. Phosphatydilinositol 3-kinase as a direct target for Ras
13. Ral GTPase mediate a distinct pathway from Ras that facilitates cellular transformation
14. Activation of type D phospholipase by serum stimulation and ras-induced transformation in NIH-3T3 cells
15. A target for phosphoinositide 3-kinase: Akt/PKB
16. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
17. Regulation of transcription by MAP kinase cascades
18. Mitogen-activated protein kinase pathways
19. Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator
20. Function and regulation of ras
21. Mos stimulates MAP kinase in Xenopus oocytes and activates a MAP kinase kinase in vitro
22. What does Mos do in oocytes and somatic cells?
23. Detection of c-mos proto-oncogene expression in human cells
24. Mos overexpression in Swiss 3T3 cells induces meiotic-like alterations of the mitotic spindle
25. Meaningful relationships: The regulation of the Ras/Raf/MEK/ERK pathway by protein interactions
26. The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells
27. Serum starved v-mos-transformed cells are unable to appropriately downregulate cyclins and CDKs
28. Deregulation of specific E2F complexes by v-mos oncogene
29. The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers
30. Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma
31. Deregulated expression of c-mos in non-small cell lung carcinomas (NSCLCs). Relationship with p53 status, genomic instability and tumor kinetics
32. C-mos immunoreactivity is an indicator of good prognosis in lung cancer
33. Relative expression of wild-type and activated Ki-ras2 oncogene in colorectal carcinomas
34. The hallmarks of cancer
35. Oncoprotein networks
36. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
37. Regulation of 92kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades
38. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins
39. Effects of PD098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion
40. Progress in understanding the molecular pathogenesis of human lung cancer
41. v-mos suppresses platelet-derived growth factor (PDGF) type-beta receptor autophosphorylation and inhibits PDGF-BB-mediated signal transduction